What the EY-Parthenon Life Sciences Strategy and Transactions Consulting team can do for you
As the life sciences industry transforms in the face of regulatory and geopolitical uncertainty and new ways of developing treatments, EY-Parthenon teams can help you answer some of your most critical questions:
Transformative strategy
- How should I refine my business strategy to find new avenues for growth while bringing innovative treatments to patients amid an ever-changing life sciences landscape?
- How can I reimagine my operating model and go-to-market strategy?
- How can I hone my organization’s strategy to strengthen its operational resilience?
- How can I leverage cutting-edge technology and therapeutic platforms to discover the next life-saving treatment?
Transformative transactions
- How can I leverage the ecosystem to scale and reach more patients effectively?
- What type of transaction, joint venture or alliance will propel our organization’s growth and pair with consumer needs?
- What is the right strategy to buy, build or partner to help reverse the innovation deficit?
EY-Parthenon Life Sciences Strategy and Transactions Consulting professionals can advise clients on developing transformative growth strategies by providing broad market, competitor and customer insights. But a strategy alone is not enough: We also help organizations execute strategy through real operational change. We help them transform the vision into reality by leveraging strategic, financial and operational perspectives based on deep sector experience and organizational knowledge to help enable execution to address society’s most pressing health problems.
Our focus includes: